Shockwave Medical to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

Rhea-AI Summary

Shockwave Medical (NASDAQ: SWAV) will participate in the SVB Leerink 11th Annual Global Healthcare Conference from February 14-18, 2022. A fireside chat featuring Shockwave management is scheduled for February 18 at 3:00 p.m. ET. Interested parties can access a live and archived webcast via the company’s website.

Shockwave Medical is focused on innovative treatments for calcified cardiovascular disease using Intravascular Lithotripsy (IVL), which utilizes sonic pressure waves to enhance patient outcomes in a minimally invasive manner.

SANTA CLARA, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company will be participating in the SVB Leerink 11th Annual Global Healthcare Conference, scheduled to be held virtually from February 14-18, 2022.

Shockwave management is scheduled for a fireside chat on Friday, February 18, 2022, at 3:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the "Investors" section of the company’s website at https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
investors@shockwavemedical.com

 

FAQ

When is Shockwave Medical's fireside chat at the SVB Leerink conference?

Shockwave Medical's fireside chat is scheduled for February 18, 2022, at 3:00 p.m. Eastern Time.

How can I access the webcast of Shockwave Medical's conference participation?

The webcast can be accessed live and archived on the 'Investors' section of Shockwave Medical’s website.

What is the purpose of Shockwave Medical's participation in the conference?

Shockwave Medical aims to discuss its innovative treatments for calcified cardiovascular disease and its development of Intravascular Lithotripsy (IVL).

What is Intravascular Lithotripsy (IVL) used for?

IVL is a technique developed by Shockwave Medical to treat complex calcified cardiovascular disease using sonic pressure waves.

When was the press release about Shockwave Medical's conference attendance issued?

The press release was issued on February 4, 2022.